Detalles de la búsqueda
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697165
2.
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
Lancet Oncol
; 23(12): 1508-1516, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400098
3.
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
BMC Cancer
; 20(1): 380, 2020 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32370765
4.
Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
J Urol
; 201(6): 1097-1104, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30741849
5.
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
BMC Cancer
; 19(1): 816, 2019 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31426760
6.
Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
Lancet Oncol
; 22(1): 6-8, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387496
7.
Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Carcinogenesis
; 35(9): 1951-61, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24562574
8.
Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions.
Ther Adv Med Oncol
; 15: 17588359231183668, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37435562
9.
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.
Cancers (Basel)
; 15(14)2023 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509333
10.
Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
Carcinogenesis
; 33(1): 49-58, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22045027
11.
Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
Gynecol Oncol
; 125(2): 441-50, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22306204
12.
Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate Cancer.
Front Oncol
; 12: 889132, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35875062
13.
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Radiother Oncol
; 169: 51-56, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35151715
14.
A Framework for Assuring the Safety, Training, Evaluation, and Wellness of Radiation Oncology Residents During the COVID-19 Pandemic (ASTEROiD-COVID19).
Adv Radiat Oncol
; 6(5): 100754, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307965
15.
Remote Contouring and Virtual Review during the COVID-19 Pandemic (RECOVR-COVID19): Results of a Quality Improvement Initiative for Virtual Resident Training in Radiation Oncology.
Curr Oncol
; 28(4): 2961-2968, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34436025
16.
Overcoming the Challenges of High Quality RNA Extraction from Core Needle Biopsy.
Biomolecules
; 11(5)2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33922016
17.
Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease: Rationale, Recent Data, and Research Questions.
Cancer J
; 26(2): 156-165, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32205541
18.
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Int J Radiat Oncol Biol Phys
; 108(4): 941-949, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562838
19.
Helpful tool or blunt instrument?-the European Association of Urology Biochemical Recurrence Risk Classification as a decision-making tool for salvage radiotherapy.
Transl Androl Urol
; 13(5): 889-892, 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38855605
20.
The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Eur Urol Focus
; 5(6): 958-969, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248849